Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07211932) titled 'Tofacitinib in Juvenile Idiopathic Arthritis' on Oct. 1.

Study Type: Observational

Primary Sponsor: Consorci Sanitari de l'Alt Penedes i Garraf

Condition: Juvenile Idiopathic Arthritis (JIA)

Intervention: Drug: Tofacitinib

Recruitment Status: Not recruiting

Date of First Enrollment: December 2025

Target Sample Size: 58

Countries of Recruitment: Spain

To know more, visit https://clinicaltrials.gov/study/NCT07211932

Published by HT Digital Content Services with permission from Health Daily Digest....